DE3400027A1 - Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer - Google Patents
Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuerInfo
- Publication number
- DE3400027A1 DE3400027A1 DE19843400027 DE3400027A DE3400027A1 DE 3400027 A1 DE3400027 A1 DE 3400027A1 DE 19843400027 DE19843400027 DE 19843400027 DE 3400027 A DE3400027 A DE 3400027A DE 3400027 A1 DE3400027 A1 DE 3400027A1
- Authority
- DE
- Germany
- Prior art keywords
- receptor
- antigen
- antibody
- animal species
- receptors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 70
- 102000036639 antigens Human genes 0.000 title claims abstract description 70
- 108091007433 antigens Proteins 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims description 48
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 27
- 239000007790 solid phase Substances 0.000 claims abstract description 25
- 238000011534 incubation Methods 0.000 claims abstract description 17
- 239000007791 liquid phase Substances 0.000 claims abstract description 8
- 239000012071 phase Substances 0.000 claims abstract description 6
- 241001465754 Metazoa Species 0.000 claims description 30
- 238000009739 binding Methods 0.000 claims description 23
- 239000000872 buffer Substances 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 11
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 239000000941 radioactive substance Substances 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims 1
- 102000005840 alpha-Galactosidase Human genes 0.000 claims 1
- 108010030291 alpha-Galactosidase Proteins 0.000 claims 1
- 102000005962 receptors Human genes 0.000 description 126
- 108020003175 receptors Proteins 0.000 description 126
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 10
- 241001494479 Pecora Species 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000011088 calibration curve Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000001488 sodium phosphate Substances 0.000 description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 4
- 101710083889 Alpha-fetoprotein Proteins 0.000 description 4
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 102000011923 Thyrotropin Human genes 0.000 description 4
- 108010061174 Thyrotropin Proteins 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229960000874 thyrotropin Drugs 0.000 description 4
- 230000001748 thyrotropin Effects 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 230000000274 adsorptive effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- PCDWFBFHIIKIPM-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-2-sulfonic acid Chemical compound C1=CC=C2N(CC)C(S(O)(=O)=O)SC2=C1 PCDWFBFHIIKIPM-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000001268 conjugating effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 2
- 229960005156 digoxin Drugs 0.000 description 2
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940040129 luteinizing hormone Drugs 0.000 description 2
- 102000051367 mu Opioid Receptors Human genes 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 239000007981 phosphate-citrate buffer Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229960001922 sodium perborate Drugs 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 108020001612 μ-opioid receptors Proteins 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
- 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843400027 DE3400027A1 (de) | 1984-01-02 | 1984-01-02 | Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer |
| IL73938A IL73938A (en) | 1984-01-02 | 1984-12-25 | Process and reagent for the determination of polyvalent antigen by incubation with three different receptors |
| JP59274244A JPS60177264A (ja) | 1984-01-02 | 1984-12-27 | 多価抗原の測定法及び測定試薬 |
| EP84116335A EP0147848B1 (de) | 1984-01-02 | 1984-12-27 | Verfahren zur Bestimmung eines polyvalenten Antigens und Reagenz hierfür |
| AT84116335T ATE69508T1 (de) | 1984-01-02 | 1984-12-27 | Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer. |
| DE8484116335T DE3485265D1 (de) | 1984-01-02 | 1984-12-27 | Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer. |
| SU843830911A SU1475492A3 (ru) | 1984-01-02 | 1984-12-28 | Способ определени поливалентного антигена |
| CA000471361A CA1244761A (en) | 1984-01-02 | 1985-01-02 | Process for the determination of a polyvalent antigen and reagent therefor |
| ZA854A ZA854B (en) | 1984-01-02 | 1985-01-02 | Method for the determination of a polyvalent antigen and reagent therefor |
| ES539297A ES8601479A1 (es) | 1984-01-02 | 1985-01-02 | Procedimiento para la deteminacion de un antigeno polivalente |
| IE785A IE58254B1 (en) | 1984-01-02 | 1985-01-02 | Process and reagent for the determination of a polyvalent antigen |
| AU37247/85A AU567998B2 (en) | 1984-01-02 | 1985-01-02 | Determination of polyvalent antigens |
| DK002085A DK165860C (da) | 1984-01-02 | 1985-01-02 | Fremgangsmaade til bestemmelse af et polyvalent antigen samt et reagens dertil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843400027 DE3400027A1 (de) | 1984-01-02 | 1984-01-02 | Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3400027A1 true DE3400027A1 (de) | 1985-07-18 |
Family
ID=6224253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19843400027 Ceased DE3400027A1 (de) | 1984-01-02 | 1984-01-02 | Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS60177264A (enrdf_load_stackoverflow) |
| DE (1) | DE3400027A1 (enrdf_load_stackoverflow) |
| SU (1) | SU1475492A3 (enrdf_load_stackoverflow) |
| ZA (1) | ZA854B (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60177264A (ja) * | 1984-01-02 | 1985-09-11 | ベ−リンガ−・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 多価抗原の測定法及び測定試薬 |
| DE3714147A1 (de) * | 1987-04-28 | 1988-11-17 | Boehringer Mannheim Gmbh | Immunchemisches verfahren und reagenz zur bestimmung eines polyvalenten antigens in einer fluessigen probe |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607101D0 (en) * | 1986-03-21 | 1986-04-30 | Serono Diagnostics Ltd | Immunoassay |
| DE3718140A1 (de) * | 1987-05-29 | 1988-12-08 | Boehringer Mannheim Gmbh | Heterogener immunoassay |
| JP2681370B2 (ja) * | 1988-06-30 | 1997-11-26 | 塩野義製薬株式会社 | 免疫測定法 |
| DE3836348A1 (de) * | 1988-10-25 | 1990-04-26 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz |
| JP2009084961A (ja) * | 2007-10-02 | 2009-04-23 | Annaka Seisakusho:Kk | オーバーヘッドドアの施錠解錠装置 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2902676A1 (de) * | 1978-01-26 | 1979-08-02 | Technicon Instr | Immunoassays unter verwendung von f(ab') tief 2 -untergruppen |
| EP0105714A1 (en) * | 1982-09-29 | 1984-04-18 | Serono Diagnostics Limited | Immunoassay of antigens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4292403A (en) * | 1978-08-24 | 1981-09-29 | Akzona Incorporated | Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins |
| DE3044385A1 (de) * | 1980-11-25 | 1982-06-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur durchfuehrung analytischer bestimmungen und hierfuer geeignetes rotoreinsatzelement |
| JPS5943360A (ja) * | 1982-09-03 | 1984-03-10 | Olympus Optical Co Ltd | 免疫学的測定方法 |
| DE3425008A1 (de) * | 1984-07-06 | 1986-02-06 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und vorrichtung zur durchfuehrung analytischer bestimmungen |
| DE3400027A1 (de) * | 1984-01-02 | 1985-07-18 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer |
-
1984
- 1984-01-02 DE DE19843400027 patent/DE3400027A1/de not_active Ceased
- 1984-12-27 JP JP59274244A patent/JPS60177264A/ja active Granted
- 1984-12-28 SU SU843830911A patent/SU1475492A3/ru active
-
1985
- 1985-01-02 ZA ZA854A patent/ZA854B/xx unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2902676A1 (de) * | 1978-01-26 | 1979-08-02 | Technicon Instr | Immunoassays unter verwendung von f(ab') tief 2 -untergruppen |
| EP0105714A1 (en) * | 1982-09-29 | 1984-04-18 | Serono Diagnostics Limited | Immunoassay of antigens |
Non-Patent Citations (1)
| Title |
|---|
| Chemical Abstracts, 1981, 95 :2368 m * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60177264A (ja) * | 1984-01-02 | 1985-09-11 | ベ−リンガ−・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 多価抗原の測定法及び測定試薬 |
| DE3714147A1 (de) * | 1987-04-28 | 1988-11-17 | Boehringer Mannheim Gmbh | Immunchemisches verfahren und reagenz zur bestimmung eines polyvalenten antigens in einer fluessigen probe |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA854B (en) | 1985-08-28 |
| SU1475492A3 (ru) | 1989-04-23 |
| JPS60177264A (ja) | 1985-09-11 |
| JPH0521428B2 (enrdf_load_stackoverflow) | 1993-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0098590B1 (de) | Immunchemisches Messverfahren | |
| EP0280211B1 (de) | Verfahren zur Bestimmung von Antikörpern | |
| DE68923800T2 (de) | Vorrichtung und verfahren zur bestimmung eines analyten in einer flüssigen probe mittels folgereaktionen. | |
| EP0397113B1 (de) | Verfahren zum Nachweis spezifisch bindefähiger Substanzen in Körperflüssigkeiten | |
| DE3783928T2 (de) | Verfahren zur immunoassay. | |
| DE68920693T2 (de) | Gefriergetrocknete Zusammensetzung, die ein mit Meerrettichperoxydase markiertes Fab'-Fragment eines gegen menschliches Beta-Interferon gerichteten Antikörpers und Trehalose enthält; EIA Kit, der diese Zusammensetzung enthält. | |
| EP0363942B1 (de) | Verfahren zur Bestimmung einer spezifisch bindefähigen Substanz | |
| EP0944832B1 (de) | ANTIGENSPEZIFISCHER IgM-NACHWEIS | |
| EP0407904B1 (de) | Verfahren zur Bestimmung eines Analyten | |
| DE3905505A1 (de) | Polymere igg-derivate zur kompensation von stoerfaktoren in immunoassays | |
| EP0752426A2 (de) | Synthetische Kalibratoren für den Einsatz in Immunoassays, bestehend aus Analyten oder Teilsequenzen davon, die an inerte Trägermoleküle konjugiert sind | |
| DE3433652A1 (de) | Immunchemisches messverfahren fuer haptene und proteine | |
| EP0291086B1 (de) | Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten | |
| EP0782585A1 (de) | RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN | |
| EP0349988A2 (de) | Verfahren zur Bestimmung einer spezifisch bindefähigen Substanz | |
| WO1998026294A1 (de) | Rezeptorbindungsassay zum nachweis von tsh-rezeptor-autoantikörpern | |
| DE19828466A1 (de) | Entstörung von Immunoassays durch Substanzen, die aus den Framework-Regionen von Antikörpern abgeleitet sind | |
| DE3852797T2 (de) | Hoch empfindlicher Immunoassay. | |
| EP0147848A2 (de) | Verfahren zur Bestimmung eines polyvalenten Antigens und Reagenz hierfür | |
| DE3400027A1 (de) | Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer | |
| DE69229960T2 (de) | Agglutierungsassays und kolloide farbstoffe verwendende testsätze | |
| EP0809805B1 (de) | Verwendung von polyklonalen humanen anti-htg-autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren | |
| EP0379216A1 (de) | Verfahren und Reagenz zur Bestimmung von immunologisch nachweisbaren Substanzen | |
| EP0289003B1 (de) | Immunchemisches Verfahren und Reagenz zur Bestimmung eines polyvalenten Antigens in einer flüssigen Probe | |
| DE3883145T2 (de) | Verfahren zur Messung von humanen Insulin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8131 | Rejection |